Men with Lynch syndrome, an inherited genetic condition linked to a higher risk of several types of cancer, face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study.

People with Lynch syndrome have up to 80 percent lifetime risk of colorectal cancer and are also more likely to develop endometrial, gastric, ovarian, urinary tract, pancreatic and brain tumors. Overall, about 1 in 440 people are carriers for the genetic mutation, making it one of the most common inherited cancer conditions.

An experiment using microvesicles generated from mesenchymal bone marrow cells to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of tumor.

Specifically, the research team found that introducing genetic material produced by mesenchymal bone marrow cells significantly reduced a particularly resistant form of malignant brain tumor in living lab rats.

An international team of physicists has proposed a revolutionary laser system inspired by telecommunications technology that could be used in both fundamental research at laboratories such as CERN and more applied tasks such as proton therapy and nuclear transmutation. 

An autonomous robotic jellyfish the size and weight of a grown man has been developed. 

Nicknamed Cyro, this prototype is a larger model of the robotic jellyfish (named RoboJelly) the same team unveiled in 2012. RoboJelly is roughly the size of a man's hand, typical of jellyfish found along beaches.

The Mind Research Network in Albuquerque says that brain scans can predict the likelihood of whether a criminal will re-offend following release from prison.

Antidepressants are commonly prescribed for depression but their efficacy is questionable -   many people don't experience symptom relief.

The National Institute of Mental Health's STAR*D study, the largest and longest study ever conducted to evaluate depression treatment, may have a better way;  identifying predictors of antidepressant response. f